Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 2,520 shares at $2.54 ($6K) on 2022-10-03, disclosed to the SEC on 2022-11-18.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.52 | 105 | $265 | 4.2% |
| 2 | $2.51 | 105 | $264 | 4.2% |
| 3 | $2.61 | 105 | $274 | 4.4% |
| 4 | $2.54 | 105 | $267 | 4.2% |
| 5 | $2.61 | 105 | $274 | 4.4% |
| 6 | $2.58 | 105 |
| $271 |
| 4.3% |
| 7 | $2.65 | 105 | $278 | 4.4% |
| 8 | $2.66 | 105 | $279 | 4.4% |
| 9 | $2.53 | 105 | $266 | 4.2% |
| 10 | $2.48 | 105 | $260 | 4.1% |
| 11 | $2.49 | 105 | $261 | 4.2% |
| 12 | $2.38 | 105 | $250 | 4.0% |
| 13 | $2.31 | 105 | $243 | 3.9% |
| 14 | $2.33 | 105 | $245 | 3.9% |
| 15 | $2.46 | 105 | $258 | 4.1% |
| 16 | $2.42 | 105 | $254 | 4.0% |
| 17 | $2.44 | 105 | $256 | 4.1% |
| 18 | $2.49 | 105 | $261 | 4.2% |
| 19 | $2.38 | 105 | $250 | 4.0% |
| 20 | $2.44 | 105 | $256 | 4.1% |
| 21 | $2.42 | 105 | $254 | 4.0% |
| 22 | $2.49 | 105 | $261 | 4.2% |
| 23 | $2.52 | 105 | $265 | 4.2% |
| 24 | $2.54 | 105 | $267 | 4.2% |
| Total | $2.49 avg | 2,520 | $6K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |